Methamphetamine-induced early increase of IL-6 and TNF-α mRNA expression in the mouse brain

Annals of the New York Academy of Sciences

Volumn 1139, Issue , 2008, Pages 103-111

  Gonçalves, Joana ^a   Martins, Tânia ^a   Ferreira, Raquel ^a   Milhazes, Nuno ^b   Borges, Fernanda ^c   Ribeiro, Carlos Fontes ^a   Malva, João O ^a   Macedo, Tice R ^a   Silva, Ana P ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Health Sciences Institute   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Cytokines; Frontal cortex; Hippocampus; Inflammation; Methamphetamine; Striatum

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; METHAMPHETAMINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; CYTOKINE PRODUCTION; DRUG ABUSE; FRONTAL CORTEX; GLIA CELL; HIPPOCAMPUS; INFLAMMATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; SINGLE DRUG DOSE;

MUS;

EID: 53549117154     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1432.043     Document Type: Article

References (42)

1. Lan, K.C., Y.F. Lin, F.C. Yu, et al. 1998. Clinical manifestations and prognostic features of acute methamphetamine intoxication. J. Formos. Med. Assoc. 97 : 528 533.
2. Thompson, P.M., K.M. Hayashi, S.L. Simon, et al. 2004. Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 24 : 6028 6036.
3. Pereira, F.C., E. Lourenço, N. Milhazes, et al. 2006. Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats. Ann. N. Y. Acad. Sci. 1074 : 160 173.
4. Pereira, F.C., S.Z. Imam, B. Gough, et al. 2002. Acute changes in dopamine release and turnover in rat caudate nucleus following a single dose of methamphetamine. J. Neural. Transm. 109 : 1151 1158.
5. Cadet, J.L., I.N. Krasnova, S. Jayanthi, et al. 2007. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox. Res. 11 : 183 202.
6. Yamamoto, B.K. & M.G. Bankson. 2005. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit. Rev. Neurobiol. 17 : 87 118.
7. Simões, A.P., A.P. Silva, F.C. Pereira, et al. 2007. Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience 150 : 433 441.
8. LaVoie, M.J., J.P. Card & T.G. Hastings. 2004. Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp. Neurol. 187 : 47 57.
9. Sriram, K., D.B. Miller & J.P. O'Callaghan. 2006. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J. Neurochem. 96 : 706 718.
10. Bowyer, J.F. & S. Ali. 2006. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 60 : 521 532.
11. Kuhn, D.M., D.M. Francescutti-Verbeem & D.M. Thomas. 2006. Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage. Ann. N. Y. Acad. Sci. 1074 : 31 41.
12. Allan, S.M. & N.J. Rothwell. 2001. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2 : 734 744.
13. Bernardino, L., S. Xappeli, A.P. Silva, et al. 2005. Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic slice cultures. J. Neurosci. 25 : 6734 6744.
14. Norris, J.G., L.P. Tang, S.M. Sparacio, et al. 1994. Signal transduction pathways mediating astrocyte IL-6 induction by IL-lbeta and tumor necrosis factor-alpha. J. Immunol. 152 : 841 850.
15. Ritchie, P.K., M. Ashby, H.H. Knight, et al. 1996. Dopamine increases interleukin 6 release and inhibits tumor necrosis factor release from rat adrenal zona glomerulosa cells in vitro. Eur. J. Endocrinol. 134 : 610 616.
16. Benveniste, E.N., S.M. Sparacio, J.G. Norris, et al. 1990. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30 : 201 212.
17. Bethea, J.R., I.Y. Chung, S.M. Sparacio, et al. 1992. Interleukin-1beta induction of tumor necrosis factor-alpha gene expression in human astroglioma cells. J. Neuroimmunol. 36 : 179 191.
18. Ladenheim, B., I.N. Krasnova, X. Deng, et al. 2000. Methamphetamine- induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol. Pharmacol. 58 : 1247 1256.
19. Yamaguchi, T., Y. Kuraishi, M. Minami, et al. 1991. Methamphetamine- induced expression of interleukin-1 beta mRNA in the rat hypothalamus. Neurosci. Lett. 128 : 90 92.
20. Nakajima, A., K. Yamada, T. Nagai, et al. 2004. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. J. Neurosci. 24 : 2212 2225.
21. Flora, G., Y.W. Lee, A. Nath, et al. 2002. Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation. Neuromolecular Med. 2 : 71 85.
22. Halladay, A.K., A. Kusnecov, L. Michna, et al. 2003. Relationship between methamphetamine-induced dopamine release, hyperthermia, self-injurious behaviour and long term dopamine depletion in BALB/c and C57BL/6 mice. Pharmacol. Toxicol. 93 : 33 41.
23. Numachi, Y., A. Ohara, M. Yamashita, et al. 2007. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur. J. Pharmacol. 572 : 120 128.
24. Basu, A., J.K. Krady & S.W. Levison. 2004. Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 78 : 151 156.
25. Liberto, C.M., P.J. Albrecht, L.M. Herx, et al. 2004. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89 : 1092 1100.
26. Parish, C.L., D.I. Finkelstein, W. Tripanichkul, et al. 2002. The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice. J. Neurosci. 22 : 8034 8041.
27. Li, L., J. Lu, S.S. Tay, S.M. Moochhala, et al. 2007. The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro. Brain Res. 1159 : 8 17.
28. Penkowa, M. & J. Hidalgo. 2000. IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment. Exp. Neurol. 163 : 72 84.
29. Penkowa, M., M. Giralt, J. Carrasco, et al. 2000. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia 32 : 271 285.
30. Yamashita, T., K. Sawamoto, S. Suzuki, et al. 2005. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J. Neurochem. 94 : 459 468.
31. Quintanilla, R.A., D.I. Orellana, C. Gonzalez-Billault, et al. 2004. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp. Cell Res. 295 : 245 257.
32. Sparkman, N.L., J.B. Buchanan, J.R.R. Heyen, et al. 2006. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J. Neurosci. 26 : 10709 10716.
33. Bluthé, R.M., B. Michaud, V. Poli, et al. 2000. Role of IL-6 in cytokine induced sickness behavior: a study IL-6 deficient mice. Physiol. Behav. 70 : 367 373.
34. Weaver, JD, M. Haung, M. Albert, et al. 2002. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59 : 371 378.
35. Balschun, D., W. Wetzel, A. del Rey, et al. 2004. Interleukin-6: a cytokine to forget. FASEB J. 18 : 1788 1790.
36. Hakkoum, D., L. Stoppini & D. Muller. 2007. Interleukin-6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures. J. Neurochem. 100 : 747 757.
37. Goodman, J.C., C.S. Robertson, R.G. Grossman, et al. 1990. Elevation of tumor necrosis factor in head injury. J. Neuroimmunol. 30 : 213 217.
38. Liu, T., R.K. Clark, P.C. McDonnell, et al. 1994. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25 : 1481 1488.
39. Rieckmann, P., S. Martins, I. Weichselbraun, et al. 1995. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 44 : 2367 2372.
40. Vezzani, A., D. Moneta, C. Richichi, et al. 2002. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 43 : 30 35.
41. Bernardino, L., R. Ferreira, A.J. Cristovao, et al. 2005. Inflammation and neurogenesis in temporal lobe epilepsy. Curr. Drug. Targets CNS Neurol. Disord. 4 : 349 360.
42. Nomura, A., H. Ujike, Y. Tanaka, et al. 2006. Association study of the tumor necrosis factor-α gene and its 1A receptor gene with methamphetamine dependence. Ann. N.Y. Acad. Sci. 1074 : 116 124.